Takeda Pharmaceutical (TAK) Intangibles: 2018-2025

  • Takeda Pharmaceutical's Intangibles fell 17.48% to $23.8 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $23.8 billion, marking a year-over-year decrease of 17.48%. This contributed to the annual value of $23.8 billion for FY2025, which is 19.57% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Intangibles of $23.8 billion as of Q1 2025, which was down 17.48% from $28.8 billion recorded in Q1 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Intangibles peaked at $36.9 billion during Q1 2021, and registered a low of $23.8 billion during Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Intangibles averaged around $28.3 billion, with its median value being $28.8 billion (2024).
  • Data for Takeda Pharmaceutical's Intangibles shows a maximum YoY decreased of 17.48% (in 2025) over the last 5 years.
  • Takeda Pharmaceutical's Intangibles (Quarterly) stood at $36.9 billion in 2021, then dropped by 11.03% to $32.9 billion in 2022, then fell by 1.76% to $32.3 billion in 2023, then fell by 10.64% to $28.8 billion in 2024, then dropped by 17.48% to $23.8 billion in 2025.
  • Its Intangibles stands at $23.8 billion for Q1 2025, versus $28.8 billion for Q1 2024 and $32.3 billion for Q1 2023.